4-(1H-吡唑-1-基)-1,3-噻唑 | 123464-70-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 4-(1H-吡唑-1-基)-1,3-噻唑
• 英文名称: 4-(1'-pyrazolyl)thiazole
• 英文别名: 4-(1-pyrazolyl)thiazole；4-(1H-pyrazol-1-yl)thiazole；4-pyrazol-1-yl-1,3-thiazole
• CAS: 123464-70-0
• 化学式: C₆H₅N₃S
• 分子量: 151.192
• InChiKey: PJUQIYFTAVZSKE-UHFFFAOYSA-N

物化性质

• 沸点：
  277.9±13.0 °C(Predicted)
• 密度：
  1.41±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  ammonium hexafluorophosphate 、 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 、 4-(1H-吡唑-1-基)-1,3-噻唑 以 乙醇 、 水 为溶剂， 以94%的产率得到
  参考文献：
  名称：

  含吡唑的新双齿配体的均配和杂配钌（II）配合物的合成，光谱学和电化学

  摘要：

  杂合[Ru（bipy）2（L–L'）] 2+和纯合[Ru（L–L'）3 ] 2+复合物，其中bipy = 2,2'-联吡啶，L–L'是九种之一制备了新的含吡唑的双齿配体。已对CD 3 CN中配合物的1 H和13 C nmr光谱进行了完全分配，并讨论了配位诱导的位移的起源。还讨论了配合物的吸收光谱和氧化还原性质。

  DOI：

  10.1039/dt9900001389
• 作为产物：
  描述：

  吡唑 、 4-氯噻唑 在 sodium hydride 、 oil 作用下， 生成 4-(1H-吡唑-1-基)-1,3-噻唑
  参考文献：
  名称：

  Steel, Peter J.; Constable, Edwin C., Journal of Chemical Research, Miniprint, 1989, # 7, p. 1601 - 1611

  摘要：

  DOI：

文献信息

• NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
  申请人：Bolea Christelle

  公开号：US20110257179A1

  公开（公告）日：2011-10-20

  The present invention relates to novel compounds of Formula (I), wherein M, P, A and (B) n are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors—subtype 4 (“mGluR4”) which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.

  本发明涉及公式（I）的新化合物，其中M，P，A和（B）n如公式（I）中所定义；发明化合物是代谢型谷氨酸受体-亚型4（“mGluR4”）的调节剂，对于治疗或预防中枢神经系统疾病以及其他由mGluR4受体调节的疾病有用。本发明还涉及制药组合物以及使用这种化合物制造药物的用途，以及使用这种化合物预防和治疗涉及mGluR4的疾病的用途。
• NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
  申请人：Boléa Christelle

  公开号：US20130210809A1

  公开（公告）日：2013-08-15

  The present invention relates to novel compounds of Formula (1), wherein M, A and B are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors-subtype 4 (“mGluR4”) which are useful for the treatment or prevention of central nervous system disorders as well other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.

  本发明涉及式（1）的新化合物，其中M，A和B如式（I）中所定义; 发明化合物是代谢型谷氨酸受体亚型4（“mGluR4”）的调节剂，可用于治疗或预防中枢神经系统疾病以及其他受mGluR4受体调节的疾病。本发明还涉及制药组合物和使用这些化合物制造药物的用途，以及使用这些化合物预防和治疗mGluR4参与的疾病的用途。
• STEEL, PETER J.;CONSTABLE, EDWIN C., J. CHEM. RES. (S),(1989) N, C. 1601-1611
  作者：STEEL, PETER J.、CONSTABLE, EDWIN C.

  DOI：——

  日期：——
• US9073907B2
  申请人：——

  公开号：US9073907B2

  公开（公告）日：2015-07-07
• [EN] NOVEL 2-AMINO-4-PYRAZOLYL-THIAZOLE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS<br/>[FR] NOUVEAUX DÉRIVÉS DE 2-AMINO-4-PYRAZOLYL-THIAZOLE ET LEUR UTILISATION EN TANT QUE MODULATEURS ALLOSTÉRIQUES DES RÉCEPTEURS MÉTABOTROPIQUES DU GLUTAMATE
  申请人：ADDEX PHARMACEUTICALS SA

  公开号：WO2012009009A2

  公开（公告）日：2012-01-19

  The present invention relates to novel compounds of Formula (1), wherein M, A and B are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors - subtype 4 ("mGluR4") which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.